38 related articles for article (PubMed ID: 23458271)
1. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
Mathey EK; Park SB; Hughes RA; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJ; Kiernan MC; Lin CS
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):973-85. PubMed ID: 25677463
[TBL] [Abstract][Full Text] [Related]
2. Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.
Fledrich R; Abdelaal T; Rasch L; Bansal V; Schütza V; Brügger B; Lüchtenborg C; Prukop T; Stenzel J; Rahman RU; Hermes D; Ewers D; Möbius W; Ruhwedel T; Katona I; Weis J; Klein D; Martini R; Brück W; Müller WC; Bonn S; Bechmann I; Nave KA; Stassart RM; Sereda MW
Nat Commun; 2018 Aug; 9(1):3025. PubMed ID: 30072689
[TBL] [Abstract][Full Text] [Related]
3. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
Ozdag Acarli AN; Tuzun E; Sanli E; Koral G; Akbayir E; Cakar A; Sirin NG; Soysal A; Aysal F; Durmus H; Parman Y; Yilmaz V
Clin Exp Immunol; 2024 Jan; 215(1):65-78. PubMed ID: 37638717
[TBL] [Abstract][Full Text] [Related]
4. Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot-Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection.
Li D; Yu H; Zhou M; Fan W; Guan Q; Li L
Front Neurol; 2024; 15():1358881. PubMed ID: 38651106
[TBL] [Abstract][Full Text] [Related]
5. p62/sequestosome-1 as a severity-reflecting plasma biomarker in Charcot-Marie-Tooth disease type 1A.
Yoon BA; Kim YH; Nam SH; Lee HJ; Oh SI; Kim N; Kim KH; Jo YR; Kim JK; Choi BO; Park HT
Sci Rep; 2024 May; 14(1):10972. PubMed ID: 38745059
[TBL] [Abstract][Full Text] [Related]
6. An Updated Review of Magnetic Resonance Neurography for Plexus Imaging.
Jung JY; Lin Y; Carrino JA
Korean J Radiol; 2023 Nov; 24(11):1114-1130. PubMed ID: 37899521
[TBL] [Abstract][Full Text] [Related]
7. CANVAS-related RFC1 mutations in patients with immune-mediated neuropathy.
Hirano M; Kuwahara M; Yamagishi Y; Samukawa M; Fujii K; Yamashita S; Ando M; Oka N; Nagano M; Matsui T; Takeuchi T; Saigoh K; Kusunoki S; Takashima H; Nagai Y
Sci Rep; 2023 Oct; 13(1):17801. PubMed ID: 37853169
[TBL] [Abstract][Full Text] [Related]
8. Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis.
Takeuchi H; Kawamura K; Kawasaki T; Oka N
Front Neurol; 2022; 13():1057767. PubMed ID: 36457867
[TBL] [Abstract][Full Text] [Related]
9. New evidence for secondary axonal degeneration in demyelinating neuropathies.
Moss KR; Bopp TS; Johnson AE; Höke A
Neurosci Lett; 2021 Jan; 744():135595. PubMed ID: 33359733
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.
Takeuchi H; Kawasaki T; Shigematsu K; Kawamura K; Oka N
Clin Rheumatol; 2017 Apr; 36(4):913-917. PubMed ID: 28124760
[TBL] [Abstract][Full Text] [Related]
11. Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.
Berger M; Allen JA
Muscle Nerve; 2015 Mar; 51(3):315-26. PubMed ID: 25418426
[TBL] [Abstract][Full Text] [Related]
12. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
Hanemann CO; Gabreëls-Fasten AA; Müller HW; Stoll G
Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A.
Nishimura T; Yoshikawa H; Fujimura H; Sakoda S; Yanagihara T
Acta Neuropathol; 1996 Nov; 92(5):454-60. PubMed ID: 8922056
[TBL] [Abstract][Full Text] [Related]
14. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
Yoshikawa H; Nishimura T; Yanagihara T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
[TBL] [Abstract][Full Text] [Related]
15. CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.
Pollard JD; Armati PJ
J Peripher Nerv Syst; 2011 Mar; 16(1):15-23. PubMed ID: 21504498
[TBL] [Abstract][Full Text] [Related]
16. Different profiles of onion bulb in CIDP and CMT1A in relation to extracellular matrix.
Oka N; Kawasaki T; Unuma T; Shigematsu K; Sugiyama H
Clin Neuropathol; 2013; 32(5):406-12. PubMed ID: 23458271
[TBL] [Abstract][Full Text] [Related]
17. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
